Laurion Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-98,896	Closed	-$1.81M	–	271
2024 Q4	$1.81M	Buy	+98,896	New	+$1.6M	0.11%	187
2020 Q4	–	Sell	-23,200	Closed	-$957K	–	608
2020 Q3	$957K	Sell	23,200 -12,527	-35%	-$541K	0.04%	461
2020 Q2	$1.73M	Buy	+35,727	New	+$1.72M	0.07%	338
2019 Q4	–	Sell	-30,600	Closed	-$1.1M	–	855
2019 Q3	$1.1M	Buy	+30,600	New	+$928K	0.05%	626
2017 Q2	–	Sell	-9,664	Closed	-$332K	–	1596
2017 Q1	$332K	Buy	+9,664	New	+$341K	0.01%	1044
2016 Q3	–	Sell	-112,100	Closed	-$3.64M	–	887
2016 Q2	$3.64M	Buy	+112,100	New	+$3.75M	0.23%	318
2015 Q3	–	Sell	-7,385	Closed	-$309K	–	717
2015 Q2	$309K	Buy	+7,385	New	+$286K	0.01%	523
2014 Q2	–	Sell	-8,300	Closed	-$202K	–	280
2014 Q1	$202K	Buy	+8,300	New	+$210K	0.08%	220